IP Explained: What is Section 101 and why reforms are needed

In today ’s IP Explained post, we’re taking a closer look at Section 101 of the United States Patent Act and how proposed reforms could both level the playing field for innovators across all sectors and ensure the U.S. remains the global leader in biopharmaceutical innovation.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Research and Development Patents Intellectual Property Patent Protections IP Explained Source Type: news